Veltex(OTC) VLXC

Market Cap$3.37M

Since IPO (1991)-100%

5 Year-97%

1 Year-64%

1 Month+11%

$0.03

+0%

+0.00Today

Veltex last closing stock price
Metric	Price	Date
Last close	USD 0.03	2026-07-28

Veltex stock price return by period
Period	Price return	Price at period start	Period start date
1 week	+10.92%	USD 0.03	2026-07-21
1 month	+10.92%	USD 0.03	2026-06-26
3 month	-16.81%	USD 0.04	2026-04-24
Year to date	-51.77%	USD 0.07	2025-12-29
1 year	-63.8%	USD 0.09	2025-07-28
3 year	-80.43%	USD 0.17	2023-07-28
5 year	-96.5%	USD 0.95	2021-07-29
Since inception	-100%	USD 27,777.78	1991-01-02

Veltex Financials at a Glance

Market Cap

$3.37M

Revenue (TTM)

$1.67M

Net Income (TTM)

-$1.61M

EPS (TTM)

-$0.02

P/E Ratio

-2.03

Dividend

$0.00

Beta (Volatility)

0.30 (Low)

Dividend

$0.00

Beta (Volatility)

0.30 (Low)

Price

$0.03

Volume

30,000

Open

$0.03

Price

$0.03

Volume

30,000

Open

$0.03

Previous Close

$0.03

Daily Range

$0.03 - $0.03

52-Week Range

$0.03 - $0.09

Estimated Earnings Date

N/A

Dividend

$0.00

Beta (Volatility)

0.30 (Low)

Price

$0.03

Volume

30,000

Open

$0.03

Previous Close

$0.03

Daily Range

$0.03 - $0.03

52-Week Range

$0.03 - $0.09

Estimated Earnings Date

N/A

VLXC News

No articles available.

Motley Fool Moneyball Superscore

Our CEO Is Handing Members His Secret Weapon

It's called Motley Fool Moneyball, our new proprietary AI tool

We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.

Get Access Now

About Veltex

Veltex Corporation is focused on creating and acquiring businesses that deliver solutions in the health, wellness, and recovery sectors. Established in 1987 and headquartered in Chicago, Illinois, the company primarily serves rehabilitation and treatment centers.

Products and Services

Health and wellness solutions for rehabilitation centers
Acquisition of businesses in the recovery sector
Consulting services for treatment facilities

Growth Outlook

Revenue increased to $413,970 in Q4 2025 from $312,710 in Q4 2024
Quarterly revenue growth indicates a positive trend in service demand
Focus on expanding service offerings to enhance market presence

Financial Highlights

Trailing twelve months (TTM) revenue of $1,300,000
Net income for Q4 2025 was -$704,356, reflecting ongoing operational challenges
Current ratio of 0.20 indicates liquidity concerns

Veltex Corporation operates in a niche market with a commitment to improving health and wellness through innovative solutions. The recent revenue growth suggests a potential recovery trajectory, although challenges remain evident in net income and liquidity ratios. The company’s strategic focus on expanding its service offerings may position it favorably for future growth in the healthcare sector. Investors may find interest in the company's efforts to enhance its market presence and operational efficiency.

AI Generated • Jul 4, 2026

Industry

Healthcare Providers and Services

Sector

Health Care

CEO

Andreas Mauritzson

Website

www.veltex.com

Headquarters

Chicago, IL 60602, US

VLXC Financials

Key Financial Metrics (TTM)

Gross Margin

70.55%

Operating Margin

-85.32%

Net Income Margin

-96.57%

Return on Equity

63.38%

Return on Capital

-453.08%

Return on Assets

-86.12%

Earnings Yield

-49.26%

Dividend Yield

0.00%

Payout Ratio

0.00%

Stock Overview

Market Cap

$3.37M

Shares Outstanding

101.37M

Volume

30.00K

Avg. Volume

24.68K

Financials (TTM)

Gross Profit

$1.17M

Operating Income

-$1.42M

EBITDA

-$1.14M

Operating Cash Flow

-$648.61K

Capital Expenditure

$0.00

Free Cash Flow

-$654.31K

Cash & ST Invst.

$3.41K

Total Debt

$3.45M

Veltex Performance Analysis

Veltex annual revenue and year-over-year revenue growth by fiscal year
Fiscal year	Period end	Revenue	YoY growth
2022	2022-12-31	USD 30,810	692.4%
2023	2023-12-31	USD 838,654	2622.0%
2024	2024-12-31	USD 1,381,258	64.7%
2025	2025-12-31	USD 1,905,185	37.9%

Veltex sequential (quarter-over-quarter) revenue growth by fiscal quarter
Fiscal quarter	Period end	QoQ growth
Q2	2025-06-30	-13.9%
Q3	2025-09-30	10.4%
Q4	2025-12-31	-17.9%
Q1	2026-03-31	-29.9%

Veltex annual diluted earnings per share and year-over-year EPS growth by fiscal year
Fiscal year	Period end	Diluted EPS	YoY growth
2022	2022-12-31	USD -0.05	18.5%
2023	2023-12-31	USD -0.01	-73.9%
2024	2024-12-31	USD -0.01	-9.3%
2025	2025-12-31	USD -0.01	13.7%

Veltex sequential (quarter-over-quarter) diluted earnings per share growth by fiscal quarter
Fiscal quarter	Period end	QoQ growth
Q2	2025-06-30	-8.0%
Q3	2025-09-30	29.6%
Q4	2025-12-31	-278.9%
Q1	2026-03-31	33.3%

Revenue Growth Rate

Annual and quarterly growth comparison

Earnings Per Share Growth Rate

Annual and quarterly EPS growth comparison

Quarterly Performance

Name

Q1 2026YOY CHG

Revenue

$290.16K

-45.3%

Gross Profit

$259.74K

-49.3%

Gross Margin

89.52%

N/A

Market Cap

$3.37M

N/A

Market Cap/Employee

$2.81K

N/A

Employees

1,200

N/A

Net Income

-$474.26K

-107.0%

EBITDA

-$328.00K

-242.2%

Quarterly Fundamentals

Name

Q1 2026YOY CHG

Total Cash

$3.41K

-45.6%

Total Debt

$3.45M

+27.3%

Accounts Receivable

$981.95K

+20.7%

Inventory

$0.00

N/A

Long Term Debt

$0.00

N/A

Short Term Debt

$3.45M

+27.3%

Return on Assets

-86.12%

N/A

Return on Invested Capital

49.03%

N/A

Free Cash Flow

-$236.23K

-336.2%

Operating Cash Flow

-$236.23K

-336.2%

Other Investments to Explore

People Also Watch

SymbolSymbol / CompanyCompanyPricePrice Chg

BVAXFBioVaxys Technology Corp.

BVAXFBioVaxys Technology Corp.$0.11+0.00%

ADMTADM Tronics Unlimited, Inc.

ADMTADM Tronics Unlimited, Inc.$0.04+0.00%

VYCOVycor Medical, Inc.

VYCOVycor Medical, Inc.$0.07+0.00%

LOBEFLobe Sciences Ltd.

LOBEFLobe Sciences Ltd.$0.01-14.29%

PMEDFQscreen Ai Inc.

PMEDFQscreen Ai Inc.$0.03+0.00%

BZYRBurzynski Research Institute, Inc.

BZYRBurzynski Research Institute, Inc.$0.01+0.00%

BICXBioCorRx Inc.

BICXBioCorRx Inc.$0.30+0.00%

Trending Stocks

SymbolSymbol / CompanyCompanyPricePrice Chg

MUUDirexion Shares ETF Trust - Direxion Daily Mu Bull 2x Shares

MUUDirexion Shares ETF Trust - Direxion Daily Mu Bull 2x Shares$19.63-0.20%

NOKNokia

NOKNokia$8.41-0.06%

SKHYSK Hynix

SKHYSK Hynix$126.79-0.03%

TQQQProShares Trust - ProShares UltraPro Qqq

TQQQProShares Trust - ProShares UltraPro Qqq$57.75-0.06%

TSLLDirexion Shares ETF Trust - Direxion Daily Tsla Bull 2x Shares

TSLLDirexion Shares ETF Trust - Direxion Daily Tsla Bull 2x Shares$6.74-0.06%

SQQQProShares Trust - ProShares UltraPro Short Qqq

SQQQProShares Trust - ProShares UltraPro Short Qqq$49.44+0.06%

INTCIntel

INTCIntel$81.88-0.05%

Questions About VLXC

What is the current price of Veltex?

Veltex is trading at $0.03 per share.

What is the 52-week range for Veltex?

Over the past 52 weeks, Veltex has traded between $0.03 and $0.09.

How much debt does Veltex have?

As of the most recent reporting period, Veltex reported total debt of $3.45M.

How much cash does Veltex have on hand?

Veltex reported $3.41K in cash and cash equivalents in its most recent financial results.

What is Veltex’s dividend yield?

Veltex does not currently have a dividend yield.

Veltex(OTC) VLXC

Veltex Financials at a Glance

VLXC News

Motley Fool Moneyball Superscore

Our CEO Is Handing Members His Secret Weapon

About Veltex

VLXC Financials

Key Financial Metrics (TTM)

Stock Overview

Financials (TTM)

Veltex Performance Analysis

Revenue Growth Rate

Earnings Per Share Growth Rate

Quarterly Performance

Quarterly Fundamentals

Other Investments to Explore

People Also Watch

Trending Stocks

Questions About VLXC

What is the current price of Veltex?

What is the 52-week range for Veltex?

How much debt does Veltex have?

How much cash does Veltex have on hand?

What is Veltex’s dividend yield?

Premium Investing Services